chr11-18303599-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_181507.2(HPS5):c.896+1823G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.423 in 152,018 control chromosomes in the GnomAD database, including 15,783 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.42 ( 15783 hom., cov: 31)
Consequence
HPS5
NM_181507.2 intron
NM_181507.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.644
Genes affected
HPS5 (HGNC:17022): (HPS5 biogenesis of lysosomal organelles complex 2 subunit 2) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. This protein interacts with Hermansky-Pudlak syndrome 6 protein and may interact with the cytoplasmic domain of integrin, alpha-3. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 5. Multiple transcript variants encoding two distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.572 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPS5 | NM_181507.2 | c.896+1823G>A | intron_variant | ENST00000349215.8 | NP_852608.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPS5 | ENST00000349215.8 | c.896+1823G>A | intron_variant | 1 | NM_181507.2 | ENSP00000265967 | P1 | |||
HPS5 | ENST00000396253.7 | c.554+1823G>A | intron_variant | 1 | ENSP00000379552 | |||||
HPS5 | ENST00000438420.6 | c.554+1823G>A | intron_variant | 1 | ENSP00000399590 | |||||
HPS5 | ENST00000531848.1 | c.554+1823G>A | intron_variant | 5 | ENSP00000431758 |
Frequencies
GnomAD3 genomes AF: 0.423 AC: 64258AN: 151900Hom.: 15779 Cov.: 31
GnomAD3 genomes
AF:
AC:
64258
AN:
151900
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.423 AC: 64276AN: 152018Hom.: 15783 Cov.: 31 AF XY: 0.424 AC XY: 31497AN XY: 74286
GnomAD4 genome
AF:
AC:
64276
AN:
152018
Hom.:
Cov.:
31
AF XY:
AC XY:
31497
AN XY:
74286
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1788
AN:
3478
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
decreased blood alpha-hydroxyisovalerate levels Other:1
association, no assertion criteria provided | research | Human Genetics, Leiden University Medical Centre | May 11, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at